Orexo Invitation to presentation of Orexos Q1 Interim Report - Marketscreener.com
| ORX Stock | SEK 9.55 0.15 1.60% |
Slightly above 52% of Orexo AB's investor base is interested to short. The analysis of current outlook of investing in Orexo AB suggests that many traders are impartial regarding Orexo AB's prospects. Orexo AB's investing sentiment can be driven by a variety of factors including economic data, Orexo AB's earnings reports, geopolitical events, and overall market trends.
Orexo |
Orexo Invitation to presentation of Orexos Q1 Interim Report Marketscreener.com
Read at news.google.com
 |
Orexo AB Fundamental Analysis
We analyze Orexo AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orexo AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orexo AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Orexo AB is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Orexo AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orexo AB stock to make a market-neutral strategy. Peer analysis of Orexo AB could also be used in its relative valuation, which is a method of valuing Orexo AB by comparing valuation metrics with similar companies.
Peers
Orexo AB Related Equities
| BIOA-B | BioArctic | 2.27 | ||||
| CAMX | Camurus AB | 2.14 | ||||
| SOBI | Swedish Orphan | 0.21 | ||||
| BINV | BioInvent International | 2.62 | ||||
| ACTI | Active Biotech | 3.85 |
Additional Tools for Orexo Stock Analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.